top of page
HLW2025_BG_InnerPages.png

From One-Size-Fits-All to Personalised Care

Partnered with:

AbbVieLogo (1).png
Untitled design (1).png
Logo_Green.png
WhatsApp Image 2025-12-24 at 10.52_edited.png
החברה הישראלית לטכנולוגיה עילית ברפואה-לוגו.png
aMoon logo_blue.png
Chairperson & Co- Founder, The Israeli Society for HealthTech and Board member of Maccabi
Novartis

Room A5

13:30 - 15:00

English

Artificial intelligence and large-scale data analytics are accelerating the shift from one-size-fits-all care to precision medicine—tailoring treatments to each patient’s genomic and personal profile. This session will examine the regulatory, ethical, and operational challenges of making personalized care accessible and sustainable, and highlight emerging global approaches shaping the future of individualized healthcare.

Panel: The Opportunity Ahead: Personalized Care Re-Defined

Moderator:

WhatsApp Image 2025-12-28 at 09.34_edited.jpg

Dr. Neomi Siegal

Head of Medical Resources Division, Maccabi Health Care

The Israeli Society for HealthTech

Shay Ben-Shachar.jpeg

Prof. Shay Ben-Shachar

Director Of Precision Medicine and Genomics

Clalit Innovation

Reut Shema.jpeg

Reut Shema

Partner

aMoon Fund

Lina Basel Salmon.jpg

Prof. Lina Basel Salmon

Director of Research and Innovation in  Genomic Medicine

Maccabi Healthcare

Ariella Toren.jpg

Dr. Ariella Toren

Senior Manager, Medical Technologies at HMO's Supervision Division

Ministry of Health, Israel

Choose Your Roundtable 

  • While data, diagnostics, and targeted therapies increasingly enable individualized care, healthcare systems remain organized around population averages, fixed budgets, and static reimbursement models. This roundtable reframes the challenge not as a question of innovation, but of institutional readiness: who carries risk, how value is measured, and how systems adapt without undermining equity or sustainability.

    WhatsApp Image 2025-12-28 at 09.34_edited.jpg

    Neomi Siegal 

    Head of Medical Resources Division, Maccabi Health Care

    The Israeli Society for HealthTech

    Noa.jpeg

    Dr Noa Geffen

    Head of Pharma Israel & Country Lead Israel

    Sanofi

    Ariella Toren.jpg

    Dr Ariella Toren

    Senior Manager, Medical Technologies at HMO's Supervision Division 

    Ministry of Health Israel.

    Oren.png

    Oren Pearlsman

    Healthcare Professional

  • If personalized medicine doesn't work for women, it doesn't work. This roundtable explores the double bind: women are both missing from the data and oversimplified when included. Through examples in therapeutics, diagnostics, and AI, we'll identify where the system breaks and what's needed to build scalable, equitable solutions.​

    MIchal Lebenthal.jpeg

    Michal Lebenthal Andreson

    Co Founder & CEO

    Impact.51

    Michal Shalem  Photo (1).jpeg

    Michal Shalem

    Co Founder & CEO

    Impact.51

    Yonit Golub Serkin, Investor and Chief Business Officer, embARC Ventures.jpeg

    Yonit Golub Serkin

    Investor and Chief Business Officer

    embARC Ventures

    Orna Berry_edited.jpg

    Dr. Orna Berry

    Former Chief Scientist

    Government of Israel

  • Despite significant advances in genomic technologies and growing evidence of their potential clinical value, personalized genomic medicine has not yet been fully integrated into routine healthcare. This roundtable focuses on the real-world use of genomics, where gaps remain, and how it can be responsibly scaled within health systems.

    Rotem Greenberg.jpg

    Rotem Greenberg

    Head of the Clinical Genetics

    Innovation Division, Clalit Health Services

    Dr. Amit Shraga,.jpg

    Dr. Amit Shraga

    Head of Data Science, Medical School

    Weizmann Institute of Science

    Shay Ben-Shachar.jpeg

    Prof. Shay Ben-Shachar

    Department Head: Genomics & Precision Medicine

    Clalit Innovation

     Dr.Karina Furmanov.png

     Dr.Karina Furmanov

    Medical Head Immunology

    Abbvie

  • This roundtable will focus on data and personalization in healthcare, a foundational element of modern medical care delivery. Meaningful personalization depends not only on advanced analytics and AI capabilities, but critically on the availability of high-quality, interoperable and longitudinal data supported by governance frameworks. Despite rapid technological progress, real-world implementation remains challenging. Regulatory constraints, fragmented data infrastructure, limited interoperability and difficulties integrating personalized insights into everyday clinical workflows continue to impede impact at scale. The discussion will explore how cross-sector collaboration between healthcare systems, industry, academia and policymakers is essential to translating personalization into measurable clinical benefit.

    Lina Basel Salmon.jpg

    Moderator:

    Prof. Lina Basel-Salmon

    Director of Research and Innovation in Genomic Medicine 

    Maccabi Healthcare

    Anat Atlas.jpg

    Anat Atlas

    Director of Data Strategy

    Maccabi Healthcare

    Renana Ashkenazi.jpg

    Renana Ashkenazi

    Managing Partner

    Grove Ventures

    Tali Yavin-Surasky.jpg

    Tali Yavin-Surasky

    Partner

    Meitar

    Moran Barak.jpg

    Dr. Moran Barak

    Medical Director

    Abbvie

  • This round table highlights the significant gaps in the cardio metabolic patient journey within Israel’s Arab community, especially during the transition from hospital to community care. These gaps stem from cultural, linguistic, and systemic barriers that impact continuity of treatment and health outcomes. We will explore practical solutions to address these challenges and improve equity in cardiometabolic care.

    Sharon Raymond.jpg

    Sharon Raymond

    Public Affairs Head & Strategic Partnerships

    Novartis Israel

    Marina.jpeg

    Marina Naomi Smolyanov

    Regional Innovation Manager

    Clalit Health Services

bottom of page